A radiolabeled-ligand-binding technique for the characterization of opioid receptors in the intact mouse vas deferens.

[1]  W. Sadee,et al.  Discrimination of three types of opioid binding sites in rat brain in vivo. , 1984, Molecular pharmacology.

[2]  J. Shaw,et al.  Multiple opiate receptors in the mouse vas deferens. , 1983, European journal of pharmacology.

[3]  C. Chavkin,et al.  Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency. , 1983, Molecular pharmacology.

[4]  E. J. Simon.  Part IX. Opiate Receptors and the Behavioral Implications of Endorphins: OPIATE RECEPTORS AND OPIOID PEPTIDES: AN OVERVIEW , 1982 .

[5]  P. Portoghese,et al.  Improved assays for the assessment of ϰ- and δ-properties of opioid ligands , 1982 .

[6]  R. Schulz,et al.  The development of opiate tolerance may dissociate from dependence. , 1982, Life sciences.

[7]  W. Sadee,et al.  [3H]diprenorphine receptor binding in vivo and in vitro. , 1982, European journal of pharmacology.

[8]  R. Schulz,et al.  Are there subtypes (isoreceptors) of multiple opiate receptors in the mouse vas deferens? , 1981, European journal of pharmacology.

[9]  R. Schulz,et al.  The preference of putative pro-enkephalins for different types of opiate receptors. , 1981, Life sciences.

[10]  R. Schulz,et al.  Multiple opiate receptors in peripheral tissue preparations. , 1981, Biochemical pharmacology.

[11]  R. Schulz,et al.  Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens. , 1980, Molecular pharmacology.

[12]  F. Leslie,et al.  Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites. , 1980, The Journal of pharmacology and experimental therapeutics.

[13]  R. Schulz,et al.  Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens , 1980, Nature.

[14]  R. Schulz,et al.  Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens. , 1980, European journal of pharmacology.

[15]  F. Leslie,et al.  Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig. , 1979, European journal of pharmacology.

[16]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[17]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[18]  A. Takemori,et al.  Studies on the quantitative antagonism of analgesics by naloxone and diprenorphine. , 1972, European journal of pharmacology.

[19]  A. Takemori,et al.  Quantitative studies on the antagonism by naloxone of some narcotic and narcotic‐antagonist analgesics , 1970, British journal of pharmacology.

[20]  A. Wartburg,et al.  Tritium-labelled cardiac glycosides: digoxin-[12α-3H]1 , 1965 .

[21]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.